Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 3Pain, Postoperative 3Neoplasms 3Lung Neoplasms 3Breast Neoplasms 3Pancreatic Neoplasms 2Pain 2Colonic Neoplasms 2Choledocholithiasis 2Choledochal Cyst 2Anxiety Disorders 2Urinary Bladder Neoplasms 1Terminal Cancer 1Stomach Neoplasms 1Solid Tumor 1Skin Neoplasms 1Sedation 1Rectal Neoplasms 1Postoperative Cognitive Complications 1Polyps 1Personal Satisfaction 1Patient Satisfaction 1Parasomnias 1Pancreatitis 1Pain, Intractable 1Opioid-Related Disorders 1Nausea 1Mouth Neoplasms 1Healthy 1Glioma 1

Interventions

methylnaltrexone 1acetaminophen, codeine drug combination 1Ultrasonic Waves 1Tramadol 1Tirzepatide 1Therapeutics 1Standard of Care 1Psilocybin 1Olanzapine 1Midazolam 1Lidocaine 1Educational Status 1Dosage Forms 1Capsules 1Buprenorphine, Naloxone Drug Combination 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Opioid-Related Disorders × Midazolam × Clear all
NCT07408193 2026-02-20

The Role of Coadministration of Lidocaine and Ketamine in Opioid-Refractory Chronic Cancer-Related Pain.

National and Kapodistrian University of Athens

Phase EARLY_PHASE1 Not yet recruiting
24 enrolled

Cancer Pain, Opioid-Related Disorders, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡